Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kewaunee Scientific (KEQU) EBIT Margin (2016 - 2026)

Kewaunee Scientific (KEQU) has 16 years of EBIT Margin data on record, last reported at 5.86% in Q4 2025.

  • For Q4 2025, EBIT Margin fell 342.0% year-over-year to 5.86%; the TTM value through Oct 2025 reached 6.89%, down 131.0%, while the annual FY2025 figure was 7.39%, 159.0% down from the prior year.
  • EBIT Margin reached 5.86% in Q4 2025 per KEQU's latest filing, down from 6.76% in the prior quarter.
  • Across five years, EBIT Margin topped out at 11.02% in Q2 2025 and bottomed at 7.4% in Q4 2021.
  • Average EBIT Margin over 5 years is 3.8%, with a median of 4.76% recorded in 2023.
  • Peak YoY movement for EBIT Margin: crashed -738bps in 2021, then soared 879bps in 2022.
  • A 5-year view of EBIT Margin shows it stood at 7.4% in 2021, then skyrocketed by 119bps to 1.38% in 2022, then soared by 632bps to 10.13% in 2023, then fell by -8bps to 9.28% in 2024, then plummeted by -37bps to 5.86% in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT Margin were 5.86% in Q4 2025, 6.76% in Q3 2025, and 11.02% in Q2 2025.